Framing Angle (from Research)
Eniola should lead with the CCT model as a memory-encoding reframe of addiction—a paradigm-shift that inverts three decades of receptor-centric dogma by targeting reward consolidation at the synaptic threshold rather than the receptor—and position herself as an independent Nigerian pharmacologist who built the mathematical architecture, ODE/RK45 validation (85.8% encoding reduction), and two working clinical platforms (IMPRINT, TOPOLOGIX) before any institution noticed. The EV pitch is: 'Tyler would be funding Eniola the way he funded the 300-follower founder—before the world catches up.' The endorsements from Berridge, Gershman, Daw, and Mattar should appear in one sentence as proof the idea has already passed the toughest peer test, not as the centrepiece—Tyler cares about the idea, not the names behind it. The budget ask should be concrete and platform-focused (e.g., compute for MCMC/HPC runs, Topologix wet-lab docking validation, patent filing) to signal she knows exactly what she would do with the money and has already been doing it without it.
Full Research →
The application materials are saved to .
Here is what the document contains:
APPLICATION NARRATIVE: Four paragraphs structured as Tyler Cowen actually reads: the problem with existing addiction pharmacotherapy first, then the CCT mechanism in plain terms, then the hard numbers (85.8% encoding reduction, 12.8 pp super-additivity, five pre-registered hypotheses confirmed), then the credential-gap framing that makes EV the right funder. Closes with the direct line: "I am not asking Tyler Cowen to bet on a credential. I am asking him to look at the work."
WHAT I WOULD DO WITH THE MONEY: $45,000 across three deliverables with specific dollar amounts grounded in real-world pricing: $18,000 for CRO patch-clamp electrophysiology on 12 hERG-flagged compounds at $1,200 each, $12,000 for GPU-accelerated MCMC at HPC cloud rates, $8,000 for PCT patent conversion, $7,000 for conference travel and six months of Lagos-cost research time.
ADDITIONAL CONTEXT: One paragraph on the tramadol-opioid epidemic in West Africa as the geographic anchor for why this work was built where it was.
CHECKLIST: 13 submission actions, including field-by-field form guidance, preprint accessibility checks, and the CGPA conversion verification.
EDITOR NOTES: Five bullets flagging the endorsement distinction (arXiv endorsement vs testimonial letter), the patent status timeline risk, EV form word-count compression needed, CRO cost verification, and the Bavarian formula CGPA conversion.